19
Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE, with a corresponding application number 210455 and regulatory information .
proudly manufactured in the
approval since 2018-07-17
Johnson & Johnson Innovative Medicine's SYMTUZA TABLET;ORAL, medication with 150MG;800MG;200MG;EQ 10MG BASE of COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE.